Gregory J. Divis, Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 13,000 shares at $7.78 ($101K) on 2020-08-12, disclosed to the SEC on 2020-08-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AVDL | BUY | 2022-05-31 | $205K | — | Filing → |